vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $70.6M, roughly 1.7× MEDALLION FINANCIAL CORP). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs 4.2%, a 13.1% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs -1.4%). Over the past eight quarters, MEDALLION FINANCIAL CORP's revenue compounded faster (15.0% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.

CLB vs MFIN — Head-to-Head

Bigger by revenue
CLB
CLB
1.7× larger
CLB
$121.8M
$70.6M
MFIN
Growing faster (revenue YoY)
MFIN
MFIN
+26.9% gap
MFIN
25.4%
-1.4%
CLB
Higher net margin
MFIN
MFIN
13.1% more per $
MFIN
17.3%
4.2%
CLB
Faster 2-yr revenue CAGR
MFIN
MFIN
Annualised
MFIN
15.0%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
MFIN
MFIN
Revenue
$121.8M
$70.6M
Net Profit
$5.1M
$12.2M
Gross Margin
Operating Margin
1.5%
29.3%
Net Margin
4.2%
17.3%
Revenue YoY
-1.4%
25.4%
Net Profit YoY
20.3%
EPS (diluted)
$0.11
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
MFIN
MFIN
Q1 26
$121.8M
Q4 25
$138.3M
$70.6M
Q3 25
$134.5M
$58.7M
Q2 25
$130.2M
$62.6M
Q1 25
$123.6M
$63.0M
Q4 24
$129.2M
$56.3M
Q3 24
$134.4M
$53.3M
Q2 24
$130.6M
$51.0M
Net Profit
CLB
CLB
MFIN
MFIN
Q1 26
$5.1M
Q4 25
$4.9M
$12.2M
Q3 25
$14.2M
$7.8M
Q2 25
$10.6M
$11.1M
Q1 25
$-154.0K
$12.0M
Q4 24
$7.4M
$10.1M
Q3 24
$11.7M
$8.6M
Q2 24
$9.0M
$7.1M
Gross Margin
CLB
CLB
MFIN
MFIN
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
MFIN
MFIN
Q1 26
1.5%
Q4 25
11.5%
29.3%
Q3 25
15.6%
33.2%
Q2 25
11.7%
31.1%
Q1 25
3.6%
32.1%
Q4 24
11.0%
32.8%
Q3 24
14.7%
26.6%
Q2 24
12.3%
24.3%
Net Margin
CLB
CLB
MFIN
MFIN
Q1 26
4.2%
Q4 25
3.6%
17.3%
Q3 25
10.6%
13.2%
Q2 25
8.2%
17.7%
Q1 25
-0.1%
19.1%
Q4 24
5.7%
18.0%
Q3 24
8.7%
16.1%
Q2 24
6.9%
13.9%
EPS (diluted)
CLB
CLB
MFIN
MFIN
Q1 26
$0.11
Q4 25
$0.11
$0.50
Q3 25
$0.30
$0.32
Q2 25
$0.22
$0.46
Q1 25
$0.00
$0.50
Q4 24
$0.15
$0.43
Q3 24
$0.25
$0.37
Q2 24
$0.19
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
MFIN
MFIN
Cash + ST InvestmentsLiquidity on hand
$22.8M
$136.3M
Total DebtLower is stronger
$216.0M
Stockholders' EquityBook value
$275.1M
$408.6M
Total Assets
$587.7M
$3.0B
Debt / EquityLower = less leverage
0.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
MFIN
MFIN
Q1 26
$22.8M
Q4 25
$22.7M
$136.3M
Q3 25
$25.6M
$72.5M
Q2 25
$31.2M
$110.4M
Q1 25
$22.1M
$131.5M
Q4 24
$19.2M
$98.2M
Q3 24
$21.5M
$120.6M
Q2 24
$17.7M
$87.7M
Total Debt
CLB
CLB
MFIN
MFIN
Q1 26
Q4 25
$110.3M
$216.0M
Q3 25
$114.1M
$215.7M
Q2 25
$124.6M
$199.9M
Q1 25
$124.4M
$199.7M
Q4 24
$126.1M
$232.2M
Q3 24
$139.9M
$232.0M
Q2 24
$147.6M
$230.8M
Stockholders' Equity
CLB
CLB
MFIN
MFIN
Q1 26
$275.1M
Q4 25
$266.0M
$408.6M
Q3 25
$271.3M
$397.4M
Q2 25
$261.3M
$389.9M
Q1 25
$253.4M
$380.2M
Q4 24
$246.6M
$370.2M
Q3 24
$250.7M
$362.4M
Q2 24
$240.3M
$354.0M
Total Assets
CLB
CLB
MFIN
MFIN
Q1 26
$587.7M
Q4 25
$584.0M
$3.0B
Q3 25
$591.4M
$2.9B
Q2 25
$602.1M
$2.9B
Q1 25
$591.5M
$2.8B
Q4 24
$585.1M
$2.9B
Q3 24
$600.5M
$2.9B
Q2 24
$597.8M
$2.8B
Debt / Equity
CLB
CLB
MFIN
MFIN
Q1 26
Q4 25
0.41×
0.53×
Q3 25
0.42×
0.54×
Q2 25
0.48×
0.51×
Q1 25
0.49×
0.53×
Q4 24
0.51×
0.63×
Q3 24
0.56×
0.64×
Q2 24
0.61×
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
MFIN
MFIN
Operating Cash FlowLast quarter
$4.0M
$126.3M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
10.35×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
MFIN
MFIN
Q1 26
$4.0M
Q4 25
$7.9M
$126.3M
Q3 25
$8.5M
$67.0M
Q2 25
$13.9M
$-10.7M
Q1 25
$6.7M
$36.3M
Q4 24
$20.6M
$108.7M
Q3 24
$13.1M
$24.6M
Q2 24
$17.1M
$27.6M
Free Cash Flow
CLB
CLB
MFIN
MFIN
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
MFIN
MFIN
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
MFIN
MFIN
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
MFIN
MFIN
Q1 26
0.77×
Q4 25
1.61×
10.35×
Q3 25
0.60×
8.63×
Q2 25
1.31×
-0.97×
Q1 25
3.02×
Q4 24
2.78×
10.72×
Q3 24
1.12×
2.86×
Q2 24
1.90×
3.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons